Anonymised, illustrative composite. The fund's confidentiality obligations to its own investors met a federal statute that makes look-through ownership disclosure a precondition of the Minister considering the application at all.
At a glance
A private fund agreed to acquire a federally licensed cannabis cultivator for $41,000,000. Its capital came from 62 limited partners across a Canadian limited partnership and an offshore feeder, with a blocker corporation between the feeder and the Canadian vehicle for tax reasons — the kind of layered structure discussed in structuring when the buyer is a non-resident. Its limited partnership agreement carried the usual investor confidentiality covenant, and several of the 62 had invested on the express footing that they would not be identified outside the fund's own records.
The application form was the obstacle, and the statute behind it. Section 62(3) of the Cannabis Act, S.C. 2018, c. 16 requires an application for a licence, or for its renewal or amendment, to be filed “with the Minister in the form and manner specified by the Minister and set out the information required by the Minister, including financial information and any information required by the regulations”.
Section 62(4) then defines the phrase in a way that reaches straight through the structure: “For the purposes of subsection (3), financial information in respect of an organization includes information about its shareholders or members and who controls it, directly or indirectly.” Not who signs the application. Not who owns the top company. Who controls it, directly or indirectly.
Section 62(5) allows the Minister to require further financial information after filing, and s.62(6) supplies the consequence: “The Minister may refuse to consider an application if any information required to be provided under any of subsections (3) to (5) is not provided.” Not refuse the application — refuse to consider it. A fund that will not name its controllers never reaches an argument on the merits.
Three tiers, 62 limited partners, a blocker and a general partner produced a disclosure population the fund had never had to assemble. Ownership disclosure was only half of it, because the same structure triggers personal vetting: s.50(b) of the Cannabis Regulations, SOR/2018-144 requires a security clearance from the directors and officers of the licence-holding corporation, from any individual exercising or in a position to exercise direct control over it, from the directors and officers of a corporation exercising such control, and from any individual who is a partner in a partnership exercising such control. Each tier added named individuals to clear, which is the subject of the clearance file.
One tier also carried a refusal risk of its own. Section 62(7)(e)(iii) lets the Minister refuse to issue, renew or amend a licence where the applicant is “an organization that was incorporated, formed or otherwise organized outside Canada”. The offshore feeder was never going to be the applicant, but the fund's first draft had the blocker sitting directly above the acquiring entity, and the blocker's own parentage was going to be on the form.
What makes s.62(4) different from the other approval regimes on a deal like this is the question it asks. The Investment Canada Act asks about the transaction: s.14(1) makes certain investments by non-Canadians reviewable by reference to the manner of acquisition and financial thresholds. The Competition Act asks about the transaction too: s.114(1) requires the parties to a proposed transaction, before it is completed, to notify the Commissioner and supply prescribed information, where the s.110 size tests are met. Both are triggered by the deal's shape and size, and neither asks who the buyer's investors are.
Section 62(4) asks about the buyer's own ownership chain, and s.62(6) makes the answer a condition of getting a decision. There is no threshold to fall under and no exemption to structure into. It is a real constraint on the confidentiality private capital normally relies on, and it is the reason some fund structures simply cannot bid for a federal cannabis licence.
Ontario's retail regime is an adjacent contrast rather than the same rule. Section 1(2) of the Cannabis Licence Act, 2018, S.O. 2018, c. 12, Sched. 2 deems a person “interested in” another where the first has a beneficial interest in the other's business, exercises direct or indirect control over it, or “has provided, or may have provided in the opinion of the Registrar based on reasonable grounds, direct or indirect financing to the other person's business”. That reaches further than control — it reaches lenders. But it feeds eligibility under s.3(4) and (5), not a precondition to the file being opened.
The fund restructured the acquisition chain rather than the fund. A single Canadian acquisition corporation was incorporated directly beneath the Canadian limited partnership, and the blocker was moved out of the control line so that the chain disclosed on the form ran: licence holder, acquisition corporation, Canadian limited partnership, general partner, and the general partner's named directors. That is a genuine narrowing, not a paper one, because control was actually relocated — the reasoning behind using a holding company above the acquisition vehicle runs the same way, from what the structure has to do rather than from what looks tidy.
The two limited partners who would not be identified moved, with their consent, into a parallel co-investment vehicle holding a non-controlling economic interest and no governance rights. Whether that put them outside “who controls it, directly or indirectly” was a documented judgment of counsel, disclosed to the Minister as such, not a line the statute draws. The LPA also had to be amended to permit disclosure of the remaining investors, which took a consent round of its own.
Filing the original structure would have produced the worst available outcome: not a refusal that could be cured, but an application the Minister declines to consider under s.62(6), with exclusivity running and a vendor free to return to the other bidder. Exclusivity ran 120 days; assembling the disclosure, amending the LPA and running the consent round took 71 of them. That work would have had to happen anyway — just from a worse position.
The tell was that nobody on the deal team could answer, in one sentence, who controlled the buyer. That is a normal state of affairs in fund structures and a fatal one in front of s.62(4). Where a target holds a federal cannabis licence, draw the control chain before the term sheet and ask which names on it the fund is contractually unable to disclose. If the answer is any of them, the structure is the problem, not the paperwork — and it is cheaper to find out before exclusivity than after.
A 30-minute call is enough to tell you whether AI pays for itself here.
Canadian small-business transaction data is not published anywhere, so most valuations in this country quote an American benchmark. The Deavo–Treadstone Acquisition Index is a daily record of Canadian listings built to replace that: asking-price distributions by province and city are published now, and days on market, departure rates and asking-to-sale spreads follow as the series lengthens. Leave an email and we will tell you as each measure lands.
No pitch, no listings. One email when the first report lands.
